Heart Mate II
Heart Mate II

Being the most widely used and clinically studied LVAD in the world, the HeartMate II offers proven reliability and safety in more than 16,000 patients worldwide with implants for more than 8 years. Extensive clinical experience with HeartMate II shows the best results and guidelines for  bridge of transplant (PTT) and target therapy (TD).

The smallest heart pump in the world. Its implantation exists a less invasive surgical procedure. Simple maintenance.